Cefoxitin, 3-carbamoyloxymethyl-7-a-methoxy-7-[2-(2-thienyl)acetamido]-3-cephem-4-carboxylic acid, is a new semisynthetic cephamycin with broad antibacterial activity. It is highly active against gram-negative microorganisms including indole-positive Proteus and Serratia strains, which are ordinarily resistant to the cephalosporins. Cefoxitin is also highly active against many strains of Escherichia coli and Proteus mirabilis which are resistant to the cephalosporins. Furthermore, E. coli and Klebsiella strains which are susceptible to the cephalosporins are generally more susceptible to the cephamycin analog. The susceptibility of the gram-positive bacteria falls well within the effective range of the antibiotic for gram-negative organisms, but cefoxitin is less active than cephalothin or cephaloridine. As is the case with the cephalosporins, strains of Pseudomonas and group D streptococci are resistant to cefoxitin. Changes in pH, inoculum density, and growth medium have no significant effect on the activity of the antibiotic.
Recently, the discovery of a new family of antibiotics, the cephamycins, has been reported (1, 3, (6) (7) (8) (9) 11) . These 7-methoxylated cephalosporins possess marked resistance to the action of ,@-lactamases from gram-positive and gramnegative organisms (10) . One of these, cephamycin C, has broad gram-negative activity but lacks significant activity against gram-positive organisms. Cefoxitin, 3-carbamoyloxymethyl-7-a -methoxy -7 -[2 -(2 -thienyl)acetamido] -3 -cephem-4-carboxylic acid ( Fig. 1) , is the result of chemical effort directed at improving the antibacterial spectrum of the cephamycins, particularly their gram-positive activity, without detracting from their gram-negative activity and their stability to f,-lactamases. This communication presents data obtained from an in vitro evaluation of cefoxitin and two clinically used cephalosporins, cephalothin and cephaloridine, by using a wide variety of clinical isolates.
(This report was presented in part at the 12th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlantic City, N.J., 26-29 September 1972.) MATERIALS AND METHODS Antibiotics. Cefoxitin was prepared in the Merck Sharp and Dohme Research Laboratories as the sodium salt. The sodium salt of cephalothin and the cephaloridine used were the commericial products (Keflin and Loridine; Eli Lilly & Co.).
Bacterial cultures. Fresh clinical isolates representing several genera of gram-positive and gramnegative bacteria were obtained from hospitals at several different geographical areas. These cultures were identified by the respective hospital microbiological laboratories, and some of the identifications were verified in our laboratories. A total of 1,483 random clinical isolates were obtained for evaluation.
A second group of 174 gram-negative microorganisms which were selected for their resistance to cephalothin were also tested.
Disk susceptibility testing. The zone of inhibition obtained with each bacterial culture with the respective antibiotics was determined by means of the Kirby-Bauer disk susceptibility testing method (2) . Mueller-Hinton (MH) agar (BBL) medium was used for these studies. When isolates of Streptococcus and Diplococcus pneumoniae were tested, the medium was supplemented with 5% defibrinated sheep blood and the tubes or plates were incubated in the presence of 10% CO2.
All Figure 2 as the cumulative percentage of isolates inhibited by increasing concentrations of antibiotic. Concurrent with the broth dilution test, the isolates were also tested by the Kirby-Bauer sensitivity test in order to allow an evaluation of the relationship between MIC and the size of the zone of inhibition. This will be discussed in a later section.
It is apparent from the MIC data that, for the gram-negative microorganisms generally susceptible to cephalothin, i.e., E. coli, Proteus mirabilis, and Klebsiella, cefoxitin was significantly more active than cephalothin. Extrapolation from the graphs in Fig. 2 indicates that for these microorganisms it takes at least four times more cephalothin than cefoxitin to inhibit 90% of the isolates. Although isolates of Enterobacter were less susceptible than the other gram-negative organisms, they were more susceptible to cefoxitin than to cephalothin. Of even greater interest is the susceptibility to cefoxitin noted among the isolates of indolepositive Proteus species and Providencia, two groups of gram-negative organisms ordinarily resistant to cephalothin (4, 13, 15) . At least 90% of the 59 isolates comprising these groups had MIC values of 12.5 ug/ml or less with cefoxitin. In addition, about one-half of the Serratia isolates had MIC values of 25 Ag or less, and 96% of them were inhibited by 100 ,g of cefoxitin per ml, whereas all were insusceptible to 100 ,ug of cephalothin per ml.
The gram-positive microorganisms, on the other hand, were less susceptible to cefoxitin than to cephalothin. All 53 isolates of Staphyloccus aureus were inhibited by 6.25 ,ug or less of cefoxitin per ml, whereas cephalothin was effective against all of the cultures at levels below 0.78 ,ug/ml, the lowest level tested. Similarly, all five pneumococcal isolates were inhibited by 3.1
Mg of cefoxitin per ml, a level appreciably higher than the <0.78 ug of cephalothin per ml required to inhibit the same isolates. The streptococci apparently are more susceptible to cefoxitin than are the staphylococci, their MICs being 0.63 ,ug/ml or less.
Since the MBCs for cefoxitin and cephalothin were generally equal to or within one to two dilution tubes of the MIC readings, the data are not presented. There was no significant shift upward in the MBC values relative to the MIC determinations.
Based on these in vitro MIC data, it can be concluded that, against gram-negative microor- The susceptibility data obtained with cefoxitin, cephalothin, and cephaloridine disks against gram-positive organisms and isolates of Haemophilus and Neisseria meningitidis are presented in Table 2 , and those obtained with gram-negative organisms are presented in Table   3 . The data in Table 2 Table 4 . They indicate that 66% of these organisms were susceptible to cefoxitin compared with 25 and 19% to cephalothin and cephaloridine, respectively. A greater number of isolates in each group, with the exception of Citrobacter (which was resistant to the three antibiotics), was susceptible to cefoxitin. Again, as in the study with random isolates, the enhanced activity of cefoxitin was due in part to the indole-positive Proteus, Providencia, and Serratia isolates against which cephalothin and cephaloridine are generally resistant. It is also significant that a respectable number of cephalothin-resistant E. coli, Proteus mirabilis, and Klebsiella were susceptible to cefoxitin. This demonstrated activity of cefoxitin against these cephalothin-resistant strains may have been due, at least in part, to the greater stability of the antibiotic to the action off,-lactamases (10). It is of interest that approximately 25% of the cultures in this group were found to be susceptible to cephalothin by our laboratory procedure, although they were selected on the basis of resistance to cephalothin. This difference was probably due to differences among laboratories in the methods used for susceptibility testing and the marginal sensitivity of some of the cultures.
Effect of pH. The effect of initial pH of the medium on antibiotic activity was evaltiated by using the agar dilution method with four gramnegative genera and S. aureus. The antibiotics were added and pH was adjusted after the medium was cooled to 50 C. The data in Table 5 indicate that there is no appreciable effect of initial pH of medium on the activity of either antibiotic. The variation in average MIC with change in initial pH was no greater than two dilution tubes, and in most instances it was no greater than one dilution tube.
Effect of inoculum size. The effect of inoculum density on antibiotic activity also was examined by using the agar dilution method with isolates of E. coli, Klebsiella, Enterobacter, and P. mirabilis. An overnight broth culture was diluted so that the number of CFU inoculated on the surface of each plate varied from approximately 103 to 106 ( was calculated for each antibiotic for each genus tested. It can be seen that inoculum size had no marked effect on the activity of any of the antibiotics studied except cephalothin. In the case of cephalothin, a significant inoculum effect was noted with isolates of E. coli, a phenomenon ascribed to the ability of strains of E. coli to deacetylate the antibiotic to its less active desacetyl analogue (14) .
Medium studies. Four growth media were tested for expression of antibiotic activity against one strain each of E. coli (L-112) and Klebsiella (L-127). The tests were conducted by the broth dilution method. The average MIC values for all three antibiotics generally fell within the range of the experimental error of the procedure (Table 7 ). In the case of cephaloridine, the average MIC value for E. coli in nutrient broth was eightfold lower than noted with two of the other media. This was not observed with the strain of Klebsiella, and its significance is not clear. Fig. 3 is given in Fig. 4 . The curve was plotted by using the method of least squares. Because of the large number of cultures involved in the construction of the curve, it was not practical to designate each culture on the curve. In defining susceptibility of an organism in terms of diameter of inhibition zone, consideration must be given to the MIC values obtained and the achievable blood levels. Therefore, the zone diameter used to define susceptibility of an organism to cefoxitin must await pharmacological studies in man and clinical experience with the antibiotic. It is clear from the cefoxitin regression curve (Fig. 4) that an 18-mm inhibition zone, which is the present cut-off point for susceptibility to the cephalosporin antibiotics, corresponds to an MIC value of 14 tig/ml.
Since the data presented indicate that the spectrum of cefoxitin is broader than that of the presently used cephalosporins, it is proposed that, in susceptibility testing, a cefoxitin disk be used in addition to the cephalothin disk, which is used to represent the clinically used cephalosporins in the Food and Drug Administration standardized procedure.
It is clear from the data presented in this paper that cefoxitin has distinct advantages in 
